Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Pro-Dex, Inc.

Pro-Dex, Inc. (PDEX) Stock Overview

Explore Pro-Dex, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PDEX●NASDAQ
HealthcareMedical - Instruments & Supplies
$61.60
$1.59(2.52%)
U.S. Market opens in 16h 7m

Pro-Dex, Inc. (PDEX)

Meyka AI Score

Z

Key Financials

Market Cap199.2M
P/E Ratio14.92
EPS (TTM)$4.13
ROE0.31%
Fundamental Analysis

AI Price Forecasts

1 Month$66.34
3 Months$76.27
1 Year Target$65.44

PDEX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Pro-Dex, Inc. (NASDAQ: PDEX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Pro-Dex, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PDEX on the NASDAQ shows an RSI of 45.24, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $65.44 for the NASDAQ listing.

Key metrics behind Pro-Dex, Inc.'s NASDAQ-traded stock include a P/E ratio of 14.92 and a market capitalization of 199.2M. Combined with our AI analysis, these give both institutional and retail investors a clear view of PDEX on the NASDAQ.

Price Performance (NASDAQ: PDEX)

1-Day Change
-2.52%
5-Day Change
-0.37%
1-Month Change
-12.03%
3-Month Change
12.24%
6-Month Change
23.60%
Year-to-Date (YTD) Change
60.08%
1-Year Change
100.59%
3-Year Change
247.73%
5-Year Change
153.81%
All-Time (Max) Change
281.90%

Contact Information

https://www.pro-dex.com
949 769 3200
2361 McGaw Avenue, Irvine, CA, 92614

Company Facts

2,040 Employees
IPO DateAug 7, 1986
CountryUS
Actively Trading

Frequently Asked Questions